The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Gene Review

Fbgl1  -  fasting blood glucose 1

Mus musculus

Synonyms: Fbg-1
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Fbgl1


High impact information on Fbgl1


Chemical compound and disease context of Fbgl1


Biological context of Fbgl1


Anatomical context of Fbgl1


Associations of Fbgl1 with chemical compounds


Other interactions of Fbgl1


Analytical, diagnostic and therapeutic context of Fbgl1


  1. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like Peptide 1 receptor. Cani, P.D., Knauf, C., Iglesias, M.A., Drucker, D.J., Delzenne, N.M., Burcelin, R. Diabetes (2006) [Pubmed]
  2. Mouse antibodies to the insulin receptor developing spontaneously as anti-idiotypes. II. Effects on glucose homeostasis and the insulin receptor. Elias, D., Maron, R., Cohen, I.R., Schechter, Y. J. Biol. Chem. (1984) [Pubmed]
  3. The effect of chronic alpha-glycosidase inhibition on diabetic nephropathy in the db/db mouse. Lee, S.M. Diabetes (1982) [Pubmed]
  4. Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) mice. Orland, M.J., Permutt, M.A. Diabetes (1987) [Pubmed]
  5. Electron microscopy of renal and ocular changes in virus-induced diabetes mellitus in mice. Rodrigues, M., Currier, C., Yoon, J. Diabetologia (1983) [Pubmed]
  6. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. Miyake, K., Ogawa, W., Matsumoto, M., Nakamura, T., Sakaue, H., Kasuga, M. J. Clin. Invest. (2002) [Pubmed]
  7. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury. Stalvey, M.S., Muller, C., Schatz, D.A., Wasserfall, C.H., Campbell-Thompson, M.L., Theriaque, D.W., Flotte, T.R., Atkinson, M.A. Diabetes (2006) [Pubmed]
  8. Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha. Park, C.W., Kim, H.W., Ko, S.H., Chung, H.W., Lim, S.W., Yang, C.W., Chang, Y.S., Sugawara, A., Guan, Y., Breyer, M.D. Diabetes (2006) [Pubmed]
  9. Dense Core Vesicle Proteins IA-2 and IA-2{beta}: Metabolic Alterations in Double Knockout Mice. Kubosaki, A., Nakamura, S., Notkins, A.L. Diabetes (2005) [Pubmed]
  10. Preserved glucoregulation but attenuation of the vascular actions of insulin in mice heterozygous for knockout of the insulin receptor. Wheatcroft, S.B., Shah, A.M., Li, J.M., Duncan, E., Noronha, B.T., Crossey, P.A., Kearney, M.T. Diabetes (2004) [Pubmed]
  11. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Tonra, J.R., Ono, M., Liu, X., Garcia, K., Jackson, C., Yancopoulos, G.D., Wiegand, S.J., Wong, V. Diabetes (1999) [Pubmed]
  12. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. Park, C.W., Zhang, Y., Zhang, X., Wu, J., Chen, L., Cha, D.R., Su, D., Hwang, M.T., Fan, X., Davis, L., Striker, G., Zheng, F., Breyer, M., Guan, Y. Kidney Int. (2006) [Pubmed]
  13. Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Yun, S.N., Moon, S.J., Ko, S.K., Im, B.O., Chung, S.H. Arch. Pharm. Res. (2004) [Pubmed]
  14. Effects of cyclo (his-pro) plus zinc on glucose metabolism in genetically diabetic obese mice. Hwang, I.K., Go, V.L., Harris, D.M., Yip, I., Kang, K.W., Song, M.K. Diabetes, obesity & metabolism. (2003) [Pubmed]
  15. Susceptibility and negative epistatic loci contributing to type 2 diabetes and related phenotypes in a KK/Ta mouse model. Shike, T., Hirose, S., Kobayashi, M., Funabiki, K., Shirai, T., Tomino, Y. Diabetes (2001) [Pubmed]
  16. Diet-induced type II diabetes in C57BL/6J mice. Surwit, R.S., Kuhn, C.M., Cochrane, C., McCubbin, J.A., Feinglos, M.N. Diabetes (1988) [Pubmed]
  17. Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression. Desai, U.J., Slosberg, E.D., Boettcher, B.R., Caplan, S.L., Fanelli, B., Stephan, Z., Gunther, V.J., Kaleko, M., Connelly, S. Diabetes (2001) [Pubmed]
  18. Prevention of diabetic nephropathy by diet control in the db/db mouse. Lee, S.M., Bressler, R. Diabetes (1981) [Pubmed]
  19. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Butler, A.E., Jang, J., Gurlo, T., Carty, M.D., Soeller, W.C., Butler, P.C. Diabetes (2004) [Pubmed]
  20. Normal thyroid thermogenesis but reduced viability and adiposity in mice lacking the mitochondrial glycerol phosphate dehydrogenase. Brown, L.J., Koza, R.A., Everett, C., Reitman, M.L., Marshall, L., Fahien, L.A., Kozak, L.P., MacDonald, M.J. J. Biol. Chem. (2002) [Pubmed]
  21. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Lee, S., Kim, W., Moon, S.O., Sung, M.J., Kim, D.H., Kang, K.P., Jang, K.Y., Lee, S.Y., Park, B.H., Koh, G.Y., Park, S.K. Nephrol. Dial. Transplant. (2007) [Pubmed]
  22. High-cholesterol diets impair short-term retention of memory in alloxan-induced diabetic mice, but not acquisition of memory nor retention of memory in prediabetic mice. Xie, W., Du, L. Life Sci. (2005) [Pubmed]
  23. Sex-limited effects of the expression of the db gene in mice during puberty. Karn, R.C. Biochem. Genet. (1981) [Pubmed]
  24. Metabolic response of mice to a postnatal ablation of CCAAT/enhancer-binding protein alpha. Yang, J., Croniger, C.M., Lekstrom-Himes, J., Zhang, P., Fenyus, M., Tenen, D.G., Darlington, G.J., Hanson, R.W. J. Biol. Chem. (2005) [Pubmed]
  25. A pharmacologic profile of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective hypoglycemic agent. Tutwiler, G.F., Kirsch, T., Bridi, G. Diabetes (1978) [Pubmed]
  26. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats. Chang, A.Y., Wyse, B.M., Gilchrist, B.J., Peterson, T., Diani, A.R. Diabetes (1983) [Pubmed]
  27. Long-Term Treatment of Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Diabetic Nephropathy through Improving Metabolic Anomalies in db/db Mice. Park, C.W., Kim, H.W., Ko, S.H., Lim, J.H., Ryu, G.R., Chung, H.W., Han, S.W., Shin, S.J., Bang, B.K., Breyer, M.D., Chang, Y.S. J. Am. Soc. Nephrol. (2007) [Pubmed]
  28. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice. Kawasaki, F., Matsuda, M., Kanda, Y., Inoue, H., Kaku, K. Am. J. Physiol. Endocrinol. Metab. (2005) [Pubmed]
  29. Chronic tumor necrosis factor-alpha infusion in gravid C57BL6/J mice accelerates adipose tissue development in female offspring. Lambin, S., van Bree, R., Vergote, I., Verhaeghe, J. J. Soc. Gynecol. Investig. (2006) [Pubmed]
  30. Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Freemark, M., Avril, I., Fleenor, D., Driscoll, P., Petro, A., Opara, E., Kendall, W., Oden, J., Bridges, S., Binart, N., Breant, B., Kelly, P.A. Endocrinology (2002) [Pubmed]
  31. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. Bali, D., Svetlanov, A., Lee, H.W., Fusco-DeMane, D., Leiser, M., Li, B., Barzilai, N., Surana, M., Hou, H., Fleischer, N. J. Biol. Chem. (1995) [Pubmed]
  32. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. Mergen, M., Mergen, H., Ozata, M., Oner, R., Oner, C. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  33. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. Erbe, D.V., Wang, S., Zhang, Y.L., Harding, K., Kung, L., Tam, M., Stolz, L., Xing, Y., Furey, S., Qadri, A., Klaman, L.D., Tobin, J.F. Mol. Pharmacol. (2005) [Pubmed]
  34. Effect of polyethylenimine on recombinant adeno-associated virus mediated insulin gene therapy. Hsu, P.Y., Yang, Y.W. The journal of gene medicine. (2005) [Pubmed]
  35. Intravascular insulin gene delivery as potential therapeutic intervention in diabetes mellitus. Yasutomi, K., Itokawa, Y., Asada, H., Kishida, T., Cui, F.D., Ohashi, S., Gojo, S., Ueda, Y., Kubo, T., Yamagishi, H., Imanishi, J., Takeuchi, T., Mazda, O. Biochem. Biophys. Res. Commun. (2003) [Pubmed]
  36. A comparison between islet transplantation and parenteral insulin in the control of diabetes and prevention of renal complications in mice. Hoffman, L., Mandel, T.E., Carter, W.M., Koulmanda, M., Martin, F.I., Campbell, D.G., McMillan, N. Metab. Clin. Exp. (1983) [Pubmed]
  37. Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Chung, S.H., Choi, C.G., Park, S.H. Arch. Pharm. Res. (2001) [Pubmed]
WikiGenes - Universities